Past activities - capacity building and advocacy:
ITPCru received Red Ribbon Award 2010. The Selecting Committee has nominated ITPCru for its activism in Eastern Europe and Central Asia. The network mobilises and trains people living with HIV in Russia to advocate for their inclusion in local, regional and international decision-making mechanisms, and facilitates information exchange, distributing crucial information through its innovative web and media campaigns. ITPCru is one of 25 community-based organizations representing 17 countries across the globe who won the award for 2010.
The cross-regional campaign “I want to be eligible - Keep it global”, targets GFATM Board members, donors and international/national organizations working on HIV to address the problem of access to GFATM resources for countries with concentrated epidemics. Launched in June, the campaign is spearheaded by the Regional Coordinators of ITPCru and MENA region. It addresses the existing criteria of distribution of GFATM funds that give priority to countries with high disease burdens and low or lower middle-income country status that left many more countries ineligible for GFATM resources. The campaign involved a rally at the IAC 2010, media campaigns, sign-on petitions, surveys and material development around GFATM eligibility criteria.
On-line action alert on drugs stock-out ITPCru facilitates discussions around stock-outs of ARVs through an online forum at www.pereboi.ru It coordinates requests on stock-outs, bridging dialogue between healthcare providers, MoH and PLHIV affected by the problems. It also seeks an immediate solution to problems by mobilizing support from communities and pharmaceutical companies to provide requested ARV drugs on a temporary basis.
Current and future activities
ITPCru is currently exploring an opportunity to find resources to continue its grant-making programme. It has been playing an instrumental role in coordinating the civil society UNGASS report. There are several meetings already planned to discuss long-term solutions to the drug-stock-outs. The Regional Community Advisory Board is also underway with discussions with civil society organisations in Eastern Europe and Central Asia and pharmaceutical companies and both of the parties have been very supportive of having a Regional CAB to monitor, advocate and participate in pricing policy and R&D.
No comments:
Post a Comment